These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 38722338)

  • 41. Inactivated Rabies Virus Vectored MERS-Coronavirus Vaccine Induces Protective Immunity in Mice, Camels, and Alpacas.
    Chi H; Wang Y; Li E; Wang X; Wang H; Jin H; Han Q; Wang Z; Wang X; Zhu A; Sun J; Zhuang Z; Zhang L; Ye J; Wang H; Feng N; Hu M; Gao Y; Zhao J; Zhao Y; Yang S; Xia X
    Front Immunol; 2022; 13():823949. PubMed ID: 35173733
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Quantification of SARS-CoV-2 neutralizing antibody by wild-type plaque reduction neutralization, microneutralization and pseudotyped virus neutralization assays.
    Bewley KR; Coombes NS; Gagnon L; McInroy L; Baker N; Shaik I; St-Jean JR; St-Amant N; Buttigieg KR; Humphries HE; Godwin KJ; Brunt E; Allen L; Leung S; Brown PJ; Penn EJ; Thomas K; Kulnis G; Hallis B; Carroll M; Funnell S; Charlton S
    Nat Protoc; 2021 Jun; 16(6):3114-3140. PubMed ID: 33893470
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Identification of an ideal adjuvant for receptor-binding domain-based subunit vaccines against Middle East respiratory syndrome coronavirus.
    Zhang N; Channappanavar R; Ma C; Wang L; Tang J; Garron T; Tao X; Tasneem S; Lu L; Tseng CT; Zhou Y; Perlman S; Jiang S; Du L
    Cell Mol Immunol; 2016 Mar; 13(2):180-90. PubMed ID: 25640653
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Human polyclonal immunoglobulin G from transchromosomic bovines inhibits MERS-CoV in vivo.
    Luke T; Wu H; Zhao J; Channappanavar R; Coleman CM; Jiao JA; Matsushita H; Liu Y; Postnikova EN; Ork BL; Glenn G; Flyer D; Defang G; Raviprakash K; Kochel T; Wang J; Nie W; Smith G; Hensley LE; Olinger GG; Kuhn JH; Holbrook MR; Johnson RF; Perlman S; Sullivan E; Frieman MB
    Sci Transl Med; 2016 Feb; 8(326):326ra21. PubMed ID: 26888429
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Challenges of convalescent plasma infusion therapy in Middle East respiratory coronavirus infection: a single centre experience.
    Ko JH; Seok H; Cho SY; Ha YE; Baek JY; Kim SH; Kim YJ; Park JK; Chung CR; Kang ES; Cho D; Müller MA; Drosten C; Kang CI; Chung DR; Song JH; Peck KR
    Antivir Ther; 2018; 23(7):617-622. PubMed ID: 29923831
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The recombinant N-terminal domain of spike proteins is a potential vaccine against Middle East respiratory syndrome coronavirus (MERS-CoV) infection.
    Jiaming L; Yanfeng Y; Yao D; Yawei H; Linlin B; Baoying H; Jinghua Y; Gao GF; Chuan Q; Wenjie T
    Vaccine; 2017 Jan; 35(1):10-18. PubMed ID: 27899228
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Seroepidemiology of Middle East respiratory syndrome (MERS) coronavirus in Saudi Arabia (1993) and Australia (2014) and characterisation of assay specificity.
    Hemida MG; Perera RA; Al Jassim RA; Kayali G; Siu LY; Wang P; Chu KW; Perlman S; Ali MA; Alnaeem A; Guan Y; Poon LL; Saif L; Peiris M
    Euro Surveill; 2014 Jun; 19(23):. PubMed ID: 24957744
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A safe and convenient pseudovirus-based inhibition assay to detect neutralizing antibodies and screen for viral entry inhibitors against the novel human coronavirus MERS-CoV.
    Zhao G; Du L; Ma C; Li Y; Li L; Poon VK; Wang L; Yu F; Zheng BJ; Jiang S; Zhou Y
    Virol J; 2013 Aug; 10():266. PubMed ID: 23978242
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Heterologous prime-boost vaccination with adenoviral vector and protein nanoparticles induces both Th1 and Th2 responses against Middle East respiratory syndrome coronavirus.
    Jung SY; Kang KW; Lee EY; Seo DW; Kim HL; Kim H; Kwon T; Park HL; Kim H; Lee SM; Nam JH
    Vaccine; 2018 Jun; 36(24):3468-3476. PubMed ID: 29739720
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Generation of MERS-CoV Pseudotyped Viral Particles for the Evaluation of Neutralizing Antibodies in Mammalian Sera.
    Almasaud A; Alharbi NK; Hashem AM
    Methods Mol Biol; 2020; 2099():117-126. PubMed ID: 31883092
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Optimization of antigen dose for a receptor-binding domain-based subunit vaccine against MERS coronavirus.
    Tang J; Zhang N; Tao X; Zhao G; Guo Y; Tseng CT; Jiang S; Du L; Zhou Y
    Hum Vaccin Immunother; 2015; 11(5):1244-50. PubMed ID: 25874632
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Nucleic acid vaccine candidates encapsulated with mesoporous silica nanoparticles against MERS-CoV.
    Almansour I; Jermy BR
    Hum Vaccin Immunother; 2024 Dec; 20(1):2346390. PubMed ID: 38691025
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Characterization and Demonstration of the Value of a Lethal Mouse Model of Middle East Respiratory Syndrome Coronavirus Infection and Disease.
    Tao X; Garron T; Agrawal AS; Algaissi A; Peng BH; Wakamiya M; Chan TS; Lu L; Du L; Jiang S; Couch RB; Tseng CT
    J Virol; 2016 Jan; 90(1):57-67. PubMed ID: 26446606
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Middle East Respiratory Syndrome Vaccine Candidates: Cautious Optimism.
    Schindewolf C; Menachery VD
    Viruses; 2019 Jan; 11(1):. PubMed ID: 30658390
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A recombinant receptor-binding domain of MERS-CoV in trimeric form protects human dipeptidyl peptidase 4 (hDPP4) transgenic mice from MERS-CoV infection.
    Tai W; Zhao G; Sun S; Guo Y; Wang Y; Tao X; Tseng CK; Li F; Jiang S; Du L; Zhou Y
    Virology; 2016 Dec; 499():375-382. PubMed ID: 27750111
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Persistence of Antibodies against Middle East Respiratory Syndrome Coronavirus.
    Payne DC; Iblan I; Rha B; Alqasrawi S; Haddadin A; Al Nsour M; Alsanouri T; Ali SS; Harcourt J; Miao C; Tamin A; Gerber SI; Haynes LM; Al Abdallat MM
    Emerg Infect Dis; 2016 Oct; 22(10):1824-6. PubMed ID: 27332149
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Assessing the Detection of Middle East Respiratory Syndrome Coronavirus IgG in Suspected and Proven Cases of Middle East Respiratory Syndrome Coronavirus Infection.
    Alhetheel A; Altalhi H; Albarrag A; Shakoor Z; Mohamed D; El-Hazmi M; Somily A; Barry M; Bakhrebah M; Nassar M
    Viral Immunol; 2017 Nov; 30(9):649-653. PubMed ID: 28873020
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Development of a recombinant replication-deficient rabies virus-based bivalent-vaccine against MERS-CoV and rabies virus and its humoral immunogenicity in mice.
    Kato H; Takayama-Ito M; Iizuka-Shiota I; Fukushi S; Posadas-Herrera G; Horiya M; Satoh M; Yoshikawa T; Yamada S; Harada S; Fujii H; Shibamura M; Inagaki T; Morimoto K; Saijo M; Lim CK
    PLoS One; 2019; 14(10):e0223684. PubMed ID: 31589656
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Middle East respiratory syndrome coronavirus infection in non-camelid domestic mammals.
    Kandeil A; Gomaa M; Shehata M; El-Taweel A; Kayed AE; Abiadh A; Jrijer J; Moatasim Y; Kutkat O; Bagato O; Mahmoud S; Mostafa A; El-Shesheny R; Perera RA; Ko RL; Hassan N; Elsokary B; Allal L; Saad A; Sobhy H; McKenzie PP; Webby RJ; Peiris M; Ali MA; Kayali G
    Emerg Microbes Infect; 2019; 8(1):103-108. PubMed ID: 30866764
    [TBL] [Abstract][Full Text] [Related]  

  • 60. MERS-CoV spike nanoparticles protect mice from MERS-CoV infection.
    Coleman CM; Venkataraman T; Liu YV; Glenn GM; Smith GE; Flyer DC; Frieman MB
    Vaccine; 2017 Mar; 35(12):1586-1589. PubMed ID: 28237499
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.